RxDoctor Payments Data

Keli Hnat, PA

Nurse Practitioner · Pittsburgh, PANPI 1396343919

Payments from drug & device makers

$795in general payments, 2019–2025

Across 12 payments — averaging $66.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$260
  • E.r. Squibb & Sons, L.L.C.$125
  • Novartis$123
  • Pfizer$100
  • AbbVie$85
  • Regeneron Healthcare Solutions, Inc.$50
  • plus $53 from 3 others

What the payments were for

  • Food & beverage$35144%
  • Education$44556%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$795 in reported general payments places this provider in the 80th percentile of 4,059 nurse practitioner providers in Pennsylvania.

See all nurse practitioner providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$6,422
Medicare patients
21
Services billed
87

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Abiraterone Acetate122$334,057
XtandiEnzalutamide17$232,159
EliquisApixaban30$23,568
Bicalutamide26$708
Prednisone173$643
Nystatin11$558
Potassium Chloride34$490
Dutasteride15$487
Ondansetron Hcl20$452
Levothyroxine Sodium45$298
Dexamethasone13$297
Hydrocortisone23$235
Famotidine30$211
Vitamin D2Ergocalciferol (Vitamin D2)23$136
Gabapentin18$87

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncXtandi$260$232,15917 claims
PfizerEliquis$100$23,56830 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,059 nurse practitioner providers in Pennsylvania.

Other nurse practitioner in Pittsburgh

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →